Papillary urothelial neoplasm of low malignant potential

From WikiMD's Food, Medicine & Wellness Encyclopedia

Punlmp2

Papillary Urothelial Neoplasm of Low Malignant Potential

Papillary urothelial neoplasm of low malignant potential (PUNLMP) is a type of bladder tumor that falls under the category of urothelial neoplasms. It is considered a low-grade tumor with minimal potential for progression to invasive cancer. PUNLMP is characterized by the presence of papillary structures lined by urothelial cells.

Characteristics[edit | edit source]

PUNLMP tumors are typically small and non-invasive, with a low likelihood of spreading to surrounding tissues or metastasizing to other parts of the body. Histologically, these tumors exhibit a papillary growth pattern and are composed of cells that closely resemble normal urothelial cells.

Diagnosis[edit | edit source]

Diagnosis of PUNLMP is usually made through cystoscopy and biopsy. Microscopic examination of the tissue sample obtained during the biopsy reveals the characteristic features of PUNLMP, such as papillary structures lined by uniform urothelial cells with minimal atypia.

Treatment[edit | edit source]

The management of PUNLMP often involves transurethral resection of the bladder tumor (TURBT) to remove the lesion. Patients with PUNLMP may require regular follow-up cystoscopies to monitor for recurrence or progression of the tumor. In some cases, intravesical therapy with agents like Bacillus Calmette-Guérin (BCG) may be recommended to prevent recurrence.

Prognosis[edit | edit source]

Overall, the prognosis for patients with PUNLMP is excellent, as these tumors have a low risk of aggressive behavior or progression to invasive disease. However, regular surveillance is essential to detect any potential changes in the tumor's behavior.


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD